about
Evaluating the scripts and thresholds of general practitioners for diagnosing heart failure in elderly peopleShort Physical Performance Battery and all-cause mortality: systematic review and meta-analysisDetection of potentially inappropriate prescribing in the very old: cross-sectional analysis of the data from the BELFRAIL observational cohort studyThe diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care.Interleukin-6 predicts short-term global functional decline in the oldest old: results from the BELFRAIL study.The glomerular filtration rate estimated by new and old equations as a predictor of important outcomes in elderly patients.Short-term prognostic value of forced expiratory volume in 1 second divided by height cubed in a prospective cohort of people 80 years and older.The correlation between blood pressure and kidney function decline in older people: a registry-based cohort study.The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and olderPredictors of poor-quality spirometry in two cohorts of older adults in Russia and Belgium: a cross-sectional study.Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based studyTreatment intentions of general practitioners regarding hypertension in the oldest old: a vignette study.A High Sense of Coherence as Protection Against Adverse Health Outcomes in Patients Aged 80 Years and Older.Diagnostic rules and algorithms for the diagnosis of non-acute heart failure in patients 80 years of age and older: a diagnostic accuracy and validation study.Significance of serum immune markers in identification of global functional impairment in the oldest old: cross-sectional results from the BELFRAIL study.Improving care for heart failure patients in primary care, GPs' perceptions: a qualitative evidence synthesis.The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling elderly: a systematic review.Correlates of dyspnoea and its association with adverse outcomes in a cohort of adults aged 80 and over.CD4:8 Ratio Above 5 Is Associated With All-Cause Mortality in CMV-Seronegative Very Old Women: Results From the BELFRAIL Study.Predictive Value of Different Expressions of Forced Expiratory Volume in 1 Second (FEV1) for Adverse Outcomes in a Cohort of Adults Aged 80 and Older.Polypharmacy in a Belgian cohort of community-dwelling oldest old (80+).Prevalence and Prognostic Impact of Valve Area-Gradient Patterns in Patients ≥80 Years With Moderate-to-Severe Aortic Stenosis (from the Prospective BELFRAIL Study).Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study.Clinical Validation of Heart Rate Apps: Mixed-Methods Evaluation Study.Multimorbidity measures were poor predictors of adverse events in patients aged ≥80 years: a prospective cohort study.General practitioners' judgement of chronic heart failure in the oldest old: Insights from the BELFRAIL study.No relation between CMV infection and mortality in the oldest old: results from the Belfrail study.CD4:8 ratio >5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL study.Association between traditional cardiovascular risk factors and mortality in the oldest old: untangling the role of frailty.No relation between vitamin D status and physical performance in the oldest old: results from the Belfrail study.The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study.Prognostic value of short-term decline of forced expiratory volume in 1 s over height cubed (FEV1/Ht(3)) in a cohort of adults aged 80 and over.Accuracy, user-friendliness and usefulness of the Cobas h232 point-of-care test for NT-proBNP in primary care.Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenarians.Estimating the prevalence of diabetes mellitus and thyroid disorders using medication data in Flanders, Belgium.The impact of confounders on the test performance of natriuretic peptides for cardiac dysfunction in subjects aged 80 and older.The relationship of multimorbidity with disability and frailty in the oldest patients: a cross-sectional analysis of three measures of multimorbidity in the BELFRAIL cohort.Should we keep on measuring multimorbidity?Methods to identify heart failure patients in general practice and their impact on patient characteristics: A systematic review.The relationship between grip strength and muscle mass (MM), inflammatory biomarkers and physical performance in community-dwelling very old persons.
P50
Q27313720-E0730F81-2152-488E-8BDE-B50F7A798C8AQ30239963-260CC1D4-4DE3-4928-87EA-195EA7C481E9Q31029947-5F6A6CAA-35D6-4B87-AD5C-0EADF4410E76Q33801510-205B519E-E200-468B-89C9-06A0AECE372FQ34543951-7641974F-3BC5-40D3-9D78-17CBF1162A26Q35091993-B8E6C723-7509-44F7-9970-25C04E84EBE3Q35132966-63AF1F34-16BF-4F1F-9BB8-F2317D084E89Q35803257-09C65370-ABA7-4147-A1B7-AC02E99A5C37Q35891148-E28BD917-BAE5-478B-BD2E-446D36F4772AQ35939401-AFB29CB3-D034-4B9C-A5F3-6EDF49624876Q35972161-4C28D34C-99B9-4130-89AA-5850780997FBQ36117277-E237DB1F-48A9-405A-A5EC-AEBDCE76D034Q37084055-5A494955-90B7-44EF-B4D5-B915AA87DDB3Q37356354-E622D627-34A4-4739-A06A-6F2604BBA723Q37470982-FC378C3D-4BA4-4D71-81DF-06987929C76FQ37516725-C83E9FBB-D032-4A43-BF6A-7CD1FE43F77CQ37589300-50082029-0876-4E33-A309-8DC582347E42Q38716931-B6D688D1-6550-43AE-88F6-2F8FF9D2942BQ39121923-C7688AFB-E0EB-4491-B19E-99A5C841A3E3Q39280372-4972D843-8731-47D1-9221-7DD5A7F4EE9CQ39830041-E6DD6C86-CEC2-41F3-8DEF-FD0CA6055F5FQ40685585-29DC710F-51AF-46CE-B34B-8B5902F5BA23Q40860936-A3C4777E-C085-45A4-BD62-E41D4110C508Q41472259-CE43D70C-A1FF-46A7-8607-0D89702DAF92Q41657931-ABA77D48-5319-4C9F-BE10-8917C99197D3Q41731992-F819D04E-7FDC-412A-B45F-BA5F9E091BFCQ42206108-0BE50658-F3BF-4A9E-AABF-BA52AFE370C1Q42227108-CE6E491D-BAB0-4E1B-AFFF-8E442DFA7DC8Q42376632-8EF828F1-6907-4A92-8190-437EBBE4B077Q45353188-43195C01-99A2-4A9C-A400-B25E9CA3F426Q46209365-FDAE7258-7B9C-4C47-87A4-7799234EBD7DQ47203783-EDFCD5C5-F9EE-4C43-B4DC-437EA65498CCQ47230844-2EACAFFC-7FA9-4D75-8CA8-CB132E5C4977Q47725391-87B5908C-2C93-49AA-BE32-7CC0433D2DA2Q47827434-6E08AE6A-34CF-4064-8A64-188C630D3DB7Q48373695-0906FF87-14C3-4C80-A5FE-A43CB31A4452Q49061021-FA67063D-589B-4179-B88E-2B096A1AEED0Q49099042-B60E1BFF-D1C1-4364-BE2A-BE51A9626E00Q50209051-A202C86A-92F6-4A3D-97E8-F280216644A3Q50856072-8FE31BFA-2721-4CE7-9788-FA4CE6C6D312
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Bert Vaes
@ast
Bert Vaes
@en
Bert Vaes
@es
Bert Vaes
@nl
type
label
Bert Vaes
@ast
Bert Vaes
@en
Bert Vaes
@es
Bert Vaes
@nl
prefLabel
Bert Vaes
@ast
Bert Vaes
@en
Bert Vaes
@es
Bert Vaes
@nl
P1153
36803862100
P31
P496
0000-0001-5244-1930